Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Acta Neuropathol
    October 2022
  1. GILVESY A, Husen E, Magloczky Z, Mihaly O, et al
    Spatiotemporal characterization of cellular tau pathology in the human locus coeruleus-pericoerulear complex by three-dimensional imaging.
    Acta Neuropathol. 2022;144:651-676.
    >> Share

    September 2022
  2. KIM B, Suh E, Nguyen AT, Prokop S, et al
    TREM2 risk variants are associated with atypical Alzheimer's disease.
    Acta Neuropathol. 2022 Sep 16. pii: 10.1007/s00401-022-02495.
    >> Share

  3. SHANG Y, Sun X, Chen X, Wang Q, et al
    A CHCHD6-APP axis connects amyloid and mitochondrial pathology in Alzheimer's disease.
    Acta Neuropathol. 2022 Sep 14. pii: 10.1007/s00401-022-02499.
    >> Share

  4. JANSEN IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, et al
    Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
    Acta Neuropathol. 2022 Sep 6. pii: 10.1007/s00401-022-02454.
    >> Share

  5. BOTELLA LUCENA P, Vanherle S, Lodder C, Gutierrez de Rave M, et al
    Blood-based Abeta42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.
    Acta Neuropathol. 2022;144:489-508.
    >> Share

    August 2022
  6. COUGHLIN DG, Goodwill VS, Standke HG, Kim Y, et al
    Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer's disease.
    Acta Neuropathol. 2022 Aug 18. pii: 10.1007/s00401-022-02480.
    >> Share

  7. GAO F, Hu M, Zhang J, Hashem J, et al
    TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury.
    Acta Neuropathol. 2022;144:187-210.
    >> Share

    July 2022
  8. BOZA-SERRANO A, Vrillon A, Minta K, Paulus A, et al
    Galectin-3 is elevated in CSF and is associated with Abeta deposits and tau aggregates in brain tissue in Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 27. pii: 10.1007/s00401-022-02469.
    >> Share

  9. AREZOUMANDAN S, Xie SX, Cousins KAQ, Mechanic-Hamilton DJ, et al
    Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 23. pii: 10.1007/s00401-022-02472.
    >> Share

  10. SEPULVEDA-FALLA D, Sanchez JS, Almeida MC, Boassa D, et al
    Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.
    Acta Neuropathol. 2022 Jul 15. pii: 10.1007/s00401-022-02467.
    >> Share

  11. DENG Y, Bi M, Delerue F, Forrest SL, et al
    Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.
    Acta Neuropathol. 2022 Jul 3. pii: 10.1007/s00401-022-02457.
    >> Share

  12. WANG SJ, Guo Y, Ervin JF, Lusk JB, et al
    Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old.
    Acta Neuropathol. 2022;144:45-57.
    >> Share

    June 2022
  13. LYSSENKO NN, Shi X, Pratico D
    The Alzheimer's disease GWAS risk alleles in the ABCA7 promoter and 5' region reduce ABCA7 expression.
    Acta Neuropathol. 2022 Jun 27. pii: 10.1007/s00401-022-02459.
    >> Share

  14. NELSON PT, Brayne C, Flanagan ME, Abner EL, et al
    Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts.
    Acta Neuropathol. 2022 Jun 13. pii: 10.1007/s00401-022-02444.
    >> Share

  15. LLOYD GM, Sorrentino ZA, Quintin S, Gorion KM, et al
    Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice.
    Acta Neuropathol. 2022;143:663-685.
    >> Share

    May 2022
  16. LEE AJ, Raghavan NS, Bhattarai P, Siddiqui T, et al
    FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease.
    Acta Neuropathol. 2022 May 24. pii: 10.1007/s00401-022-02431.
    >> Share

  17. PLOWEY ED, Bussiere T, Rajagovindan R, Sebalusky J, et al
    Alzheimer disease neuropathology in a patient previously treated with aducanumab.
    Acta Neuropathol. 2022 May 17. pii: 10.1007/s00401-022-02433.
    >> Share

  18. CHEN S, Acosta D, Li L, Liang J, et al
    Wolframin is a novel regulator of tau pathology and neurodegeneration.
    Acta Neuropathol. 2022;143:547-569.
    >> Share

  19. CYKOWSKI MD, Arumanayagam AS, Powell SZ, Rivera AL, et al
    Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
    Acta Neuropathol. 2022;143:531-545.
    >> Share

    April 2022
  20. JIN Y, Li F, Sonoustoun B, Kondru NC, et al
    APOE4 exacerbates alpha-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
    Acta Neuropathol. 2022 Apr 26. pii: 10.1007/s00401-022-02421.
    >> Share

  21. BOUTER Y, Liekefeld H, Pichlo S, Westhoff AC, et al
    Donanemab detects a minor fraction of amyloid-beta plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.
    Acta Neuropathol. 2022 Apr 16. pii: 10.1007/s00401-022-02418.
    >> Share

  22. RAMANAN VK, Heckman MG, Lesnick TG, Przybelski SA, et al
    Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.
    Acta Neuropathol. 2022 Apr 12. pii: 10.1007/s00401-022-02419.
    >> Share

  23. BARON T, Arsac JN, Verchere J, Tlili H, et al
    Co-expression of APP/PS1 disrupts the distribution of brain lesions in a synucleinopathy transgenic mouse model (M83).
    Acta Neuropathol. 2022;143:527-529.
    >> Share

    March 2022
  24. KAPASI A, Yu L, Petyuk V, Arfanakis K, et al
    Association of small vessel disease with tau pathology.
    Acta Neuropathol. 2022;143:349-362.
    >> Share

  25. PEROSA V, Oltmer J, Munting LP, Freeze WM, et al
    Perivascular space dilation is associated with vascular amyloid-beta accumulation in the overlying cortex.
    Acta Neuropathol. 2022;143:331-348.
    >> Share

    February 2022
  26. SMIRNOV DS, Ashton NJ, Blennow K, Zetterberg H, et al
    Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.
    Acta Neuropathol. 2022 Feb 23. pii: 10.1007/s00401-022-02408.
    >> Share

  27. KAESER SA, Hasler LM, Lambert M, Bergmann C, et al
    CSF p-tau increase in response to Abeta-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles.
    Acta Neuropathol. 2022;143:287-290.
    >> Share

  28. BOWLES KR, Pugh DA, Oja LM, Jadow BM, et al
    Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD.
    Acta Neuropathol. 2022;143:225-243.
    >> Share

    January 2022
  29. UEMURA MT, Robinson JL, Cousins KAQ, Tropea TF, et al
    Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Acta Neuropathol. 2022;143:15-31.
    >> Share

    November 2021
  30. SMITH AM, Davey K, Tsartsalis S, Khozoie C, et al
    Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology.
    Acta Neuropathol. 2021 Nov 12. pii: 10.1007/s00401-021-02372.
    >> Share

    October 2021
  31. MCALEESE KE, Miah M, Graham S, Hadfield GM, et al
    Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.
    Acta Neuropathol. 2021 Oct 4. pii: 10.1007/s00401-021-02376.
    >> Share

  32. ROOS TT, Garcia MG, Martinsson I, Mabrouk R, et al
    Neuronal spreading and plaque induction of intracellular Abeta and its disruption of Abeta homeostasis.
    Acta Neuropathol. 2021;142:669-687.
    >> Share

  33. MAO F, Robinson JL, Unger T, Posavi M, et al
    TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
    Acta Neuropathol. 2021;142:629-642.
    >> Share

    September 2021
  34. FELEKE R, Reynolds RH, Smith AM, Tilley B, et al
    Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases.
    Acta Neuropathol. 2021;142:449-474.
    >> Share

    August 2021
  35. HALLINAN GI, Hoq MR, Ghosh M, Vago FS, et al
    Structure of Tau filaments in Prion protein amyloidoses.
    Acta Neuropathol. 2021;142:227-241.
    >> Share

  36. WALLON D, Boluda S, Rovelet-Lecrux A, Thierry M, et al
    Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers.
    Acta Neuropathol. 2021;142:259-278.
    >> Share

    July 2021
  37. CHEN CD, Joseph-Mathurin N, Sinha N, Zhou A, et al
    Comparing amyloid-beta plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
    Acta Neuropathol. 2021 Jul 28. pii: 10.1007/s00401-021-02342.
    >> Share

    June 2021
  38. DIAZ-LUCENA D, Kruse N, Thune K, Schmitz M, et al
    TREM2 expression in the brain and biological fluids in prion diseases.
    Acta Neuropathol. 2021;141:841-859.
    >> Share

    May 2021
  39. JAUNMUKTANE Z, Banerjee G, Paine S, Parry-Jones A, et al
    Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-beta transmission.
    Acta Neuropathol. 2021 May 28. pii: 10.1007/s00401-021-02326.
    >> Share

  40. DAVE N, Vural AS, Piras IS, Winslow W, et al
    Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Acta Neuropathol. 2021 May 12. pii: 10.1007/s00401-021-02323.
    >> Share

  41. GARCIA-ESCUDERO V, Ruiz-Gabarre D, Gargini R, Perez M, et al
    A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    Acta Neuropathol. 2021 May 2. pii: 10.1007/s00401-021-02317.
    >> Share

    April 2021
  42. KANG SS, Ahn EH, Liu X, Bryson M, et al
    ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2021 Apr 25. pii: 10.1007/s00401-021-02315.
    >> Share

  43. VALVERDE A, Dunys J, Lorivel T, Debayle D, et al
    Aminopeptidase A contributes to biochemical, anatomical and cognitive defects in Alzheimer's disease (AD) mouse model and is increased at early stage in sporadic AD brain.
    Acta Neuropathol. 2021 Apr 21. pii: 10.1007/s00401-021-02308.
    >> Share

  44. SHI Y, Murzin AG, Falcon B, Epstein A, et al
    Correction to: Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
    Acta Neuropathol. 2021 Apr 8. pii: 10.1007/s00401-021-02303.
    >> Share

  45. TOME SO, Gomes LA, Li X, Vandenberghe R, et al
    TDP-43 interacts with pathological tau protein in Alzheimer's disease.
    Acta Neuropathol. 2021 Apr 2. pii: 10.1007/s00401-021-02295.
    >> Share

    March 2021
  46. SHI Y, Murzin AG, Falcon B, Epstein A, et al
    Cryo-EM structures of tau filaments from Alzheimer's disease with PET ligand APN-1607.
    Acta Neuropathol. 2021 Mar 16. pii: 10.1007/s00401-021-02294.
    >> Share

    February 2021
  47. GERRITS E, Brouwer N, Kooistra SM, Woodbury ME, et al
    Distinct amyloid-beta and tau-associated microglia profiles in Alzheimer's disease.
    Acta Neuropathol. 2021 Feb 20. pii: 10.1007/s00401-021-02263.
    >> Share

  48. CACACE R, Van Broeckhoven C
    Reply: Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.
    Acta Neuropathol. 2021 Feb 16. pii: 10.1007/s00401-021-02277.
    >> Share

  49. KIROLA L, Budde JP, Wang F, Norton J, et al
    Lack of evidence supporting a role for DPP6 sequence variants in Alzheimer's disease in the European American population.
    Acta Neuropathol. 2021 Feb 16. pii: 10.1007/s00401-021-02271.
    >> Share

  50. ASHTON NJ, Pascoal TA, Karikari TK, Benedet AL, et al
    Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
    Acta Neuropathol. 2021 Feb 14. pii: 10.1007/s00401-021-02275.
    >> Share

  51. ARAGAO GOMES L, Uytterhoeven V, Lopez-Sanmartin D, Tome SO, et al
    Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation.
    Acta Neuropathol. 2021;141:173-192.
    >> Share

  52. XU H, O'Reilly M, Gibbons GS, Changolkar L, et al
    In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.
    Acta Neuropathol. 2021;141:193-215.
    >> Share

    January 2021
  53. HONDIUS DC, Koopmans F, Leistner C, Pita-Illobre D, et al
    The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer's disease.
    Acta Neuropathol. 2021 Jan 25. pii: 10.1007/s00401-020-02261.
    >> Share

  54. MATCHETT BJ, Grinberg LT, Theofilas P, Murray ME, et al
    The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2021 Jan 11. pii: 10.1007/s00401-020-02248.
    >> Share

    December 2020
  55. SEPULVEDA-FALLA D, Chavez-Gutierrez L, Portelius E, Velez JI, et al
    A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
    Acta Neuropathol. 2020 Dec 14. pii: 10.1007/s00401-020-02249.
    >> Share

    October 2020
  56. VAILLANT-BEUCHOT L, Mary A, Pardossi-Piquard R, Bourgeois A, et al
    Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains.
    Acta Neuropathol. 2020 Oct 20. pii: 10.1007/s00401-020-02234.
    >> Share

    September 2020
  57. EVANS CE, Miners JS, Piva G, Willis CL, et al
    Correction to: ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Acta Neuropathol. 2020 Sep 27. pii: 10.1007/s00401-020-02229.
    >> Share

  58. BOON BDC, Bulk M, Jonker AJ, Morrema THJ, et al
    The coarse-grained plaque: a divergent Abeta plaque-type in early-onset Alzheimer's disease.
    Acta Neuropathol. 2020 Sep 14. pii: 10.1007/s00401-020-02198.
    >> Share

    August 2020
  59. KORTE N, Nortley R, Attwell D
    Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease.
    Acta Neuropathol. 2020 Aug 31. pii: 10.1007/s00401-020-02215.
    >> Share

  60. NGUYEN AT, Wang K, Hu G, Wang X, et al
    APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
    Acta Neuropathol. 2020 Aug 25. pii: 10.1007/s00401-020-02200.
    >> Share

  61. IKONOMOVIC MD, Buckley CJ, Abrahamson EE, Kofler JK, et al
    Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-beta plaques in Alzheimer's disease.
    Acta Neuropathol. 2020 Aug 9. pii: 10.1007/s00401-020-02175.
    >> Share

  62. DAI DL, Tropea TF, Robinson JL, Suh E, et al
    ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
    Acta Neuropathol. 2020 Aug 4. pii: 10.1007/s00401-020-02199.
    >> Share

  63. LAU HHC, Ingelsson M, Watts JC
    The existence of Abeta strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.
    Acta Neuropathol. 2020 Aug 2. pii: 10.1007/s00401-020-02201.
    >> Share

    July 2020
  64. KENT SA, Spires-Jones TL, Durrant CS
    The physiological roles of tau and Abeta: implications for Alzheimer's disease pathology and therapeutics.
    Acta Neuropathol. 2020 Jul 29. pii: 10.1007/s00401-020-02196.
    >> Share

  65. LANTERO RODRIGUEZ J, Karikari TK, Suarez-Calvet M, Troakes C, et al
    Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
    Acta Neuropathol. 2020 Jul 27. pii: 10.1007/s00401-020-02195.
    >> Share

  66. READHEAD B, Haure-Mirande JV, Mastroeni D, Audrain M, et al
    miR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease.
    Acta Neuropathol. 2020 Jul 14. pii: 10.1007/s00401-020-02185.
    >> Share

    June 2020
  67. YOUNAS N, Zafar S, Shafiq M, Noor A, et al
    SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
    Acta Neuropathol. 2020 Jun 23. pii: 10.1007/s00401-020-02178.
    >> Share

    April 2020
  68. DEMAREST TG, Varma VR, Estrada D, Babbar M, et al
    Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.
    Acta Neuropathol. 2020 Apr 24. pii: 10.1007/s00401-020-02152.
    >> Share

    February 2020
  69. LIU G, Zhang H, Liu B, Wang T, et al
    rs4147929 variant minor allele increases ABCA7 gene expression and ABCA7 shows increased gene expression in Alzheimer's disease patients compared with controls.
    Acta Neuropathol. 2020 Feb 29. pii: 10.1007/s00401-020-02135.
    >> Share

  70. SLEEGERS K
    Expression of ABCA7 in Alzheimer's disease.
    Acta Neuropathol. 2020 Feb 28. pii: 10.1007/s00401-020-02136.
    >> Share

  71. SHI H, Koronyo Y, Rentsendorj A, Regis GC, et al
    Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina.
    Acta Neuropathol. 2020 Feb 10. pii: 10.1007/s00401-020-02134.
    >> Share

    January 2020
  72. EVANS CE, Miners JS, Piva G, Willis CL, et al
    ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Acta Neuropathol. 2020 Jan 25. pii: 10.1007/s00401-019-02098.
    >> Share

  73. VAN DER LEE SJ, Conway OJ, Jansen I, Carrasquillo MM, et al
    Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
    Acta Neuropathol. 2020 Jan 18. pii: 10.1007/s00401-019-02107.
    >> Share

  74. SMITH R, Pawlik D, Nilsson CF, Englund E, et al
    [18F]Flortaucipir distinguishes Alzheimer's disease from progressive supranuclear palsy pathology in a mixed-pathology case.
    Acta Neuropathol. 2020 Jan 4. pii: 10.1007/s00401-019-02121.
    >> Share

    December 2019
  75. THIERRY M, Boluda S, Delatour B, Marty S, et al
    Human subiculo-fornico-mamillary system in Alzheimer's disease: Tau seeding by the pillar of the fornix.
    Acta Neuropathol. 2019 Dec 10. pii: 10.1007/s00401-019-02108.
    >> Share

  76. KOPER MJ, Van Schoor E, Ospitalieri S, Vandenberghe R, et al
    Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer's disease.
    Acta Neuropathol. 2019 Dec 4. pii: 10.1007/s00401-019-02103.
    >> Share

    February 2019
  77. JOSEPHS KA, Murray ME, Tosakulwong N, Weigand SD, et al
    Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
    Acta Neuropathol. 2019;137:227-238.
    >> Share

  78. NICOLAS G, Veltman JA
    The role of de novo mutations in adult-onset neurodegenerative disorders.
    Acta Neuropathol. 2019;137:183-207.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016